Azithromycin

阿奇霉素

Report date: 2026/04/20 20:01:59
NMEQIDP

Base Information

Drug NameAzithromycin
Drug Alias Name阿齐霉素Zytromax EV阿奇毒素AzithromycinumAzithromycine +[30] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Uncomplicated skin and skin structure infectionsCommunity Acquired Pneumonia +[87] 
Global Approved IndicationsCommunity Acquired PneumoniaAcute bacterial skin and skin structure infectionsUterine Cervicitis +[11] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1991/11/01
Country/TerritoryFormer Serbia and MontenegroBelgiumCanada +[65] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Nutrition Of Central America And PanamaKinshasa School Of Public HealthUniversity of Child Health Sciences and Children's Hospital, Lahore +[32] 
Inactive CompaniesUniversity Of Maryland, College ParkInstitut National De La Santé Et De La Recherche Médicale, France U979Sandoz +[44] 
Active IndicationsUncomplicated skin and skin structure infectionsCommunity-acquired bacterial pneumoniaDiarrhea +[36] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Community Acquired PneumoniaAcute bacterial skin and skin structure infections +[51] 

Other Information

ATC CodeJ01FA10S01AA26
Related LinksWikipediaDrugBankKEGG